65/100 · Elevated
Manufactured by Walgreens
Moderate Safety Concerns with DocuSate Sodium and Sennosides
13,062 FDA adverse event reports analyzed
Last updated: 2026-05-12
DOCUSATE SODIUM AND SENNOSIDES is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Walgreens. Based on analysis of 13,062 FDA adverse event reports, DOCUSATE SODIUM AND SENNOSIDES has a safety score of 65 out of 100. This moderate score indicates a notable volume of adverse event reports that patients and providers should be aware of. The most commonly reported adverse reactions for DOCUSATE SODIUM AND SENNOSIDES include FATIGUE, NAUSEA, CONSTIPATION, DIARRHOEA, DYSPNOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DOCUSATE SODIUM AND SENNOSIDES.
Docusate Sodium And Sennosides has a safety concern score of 65 out of 100, placing it in the elevated concern category based on analysis of FDA adverse event data. The FDA has received approximately 13,062 adverse event reports for this medication, which is primarily manufactured by Walgreens.
The most commonly reported adverse events include Fatigue, Nausea, Constipation. Of classified reports, 59.4% were designated as serious by the FDA, meaning they involved hospitalization, disability, or other significant medical outcomes. Fatigue and nausea are the most common side effects, with a significant number of reports involving serious adverse events like pneumonia and death.
The drug is associated with a range of gastrointestinal issues, including constipation, diarrhea, and abdominal pain. There are reports of cardiovascular issues, such as atrial fibrillation and congestive heart failure, though these are less frequent.
Patients taking Docusate Sodium And Sennosides should monitor for the commonly reported side effects and contact their healthcare provider if they experience any unusual symptoms. DocuSate Sodium and Sennosides may interact with other medications, particularly those affecting the cardiovascular system, and should be used with caution. This analysis is based on voluntary FDA adverse event reports and should not replace professional medical advice.
Docusate Sodium And Sennosides received a safety concern score of 65/100 (elevated concern). This is based on a 59.4% serious event ratio across 5,490 classified reports. The score accounts for 13,062 total adverse event reports and 100 distinct reaction types. This elevated score indicates a notable proportion of serious adverse events and warrants careful monitoring.
Adverse event reports by sex: Female: 3,326, Male: 2,024, Unknown: 6. The most frequently reported age groups are age 68 (115 reports), age 69 (105 reports), age 72 (102 reports). These demographics reflect reporting patterns and may not represent the full patient population.
Out of 5,490 classified reports for DOCUSATE SODIUM AND SENNOSIDES:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
DocuSate Sodium and Sennosides may interact with other medications, particularly those affecting the cardiovascular system, and should be used with caution.
If you are taking Docusate Sodium And Sennosides, here are important things to know. The most commonly reported side effects include fatigue, nausea, constipation, diarrhoea, dyspnoea. While many of these may be mild and temporary, you should contact your healthcare provider if any symptoms are severe or persistent. Monitor for signs of serious adverse events such as pneumonia, heart issues, and gastrointestinal problems. Follow prescribed dosages and use as directed to minimize the risk of side effects. If you experience a serious adverse reaction, seek emergency medical attention immediately or call 911. You can report side effects to the FDA's MedWatch program at 1-800-FDA-1088.
The FDA has received a significant number of adverse event reports, suggesting a need for ongoing monitoring and potential regulatory action.
The FDA has received approximately 13,062 adverse event reports associated with Docusate Sodium And Sennosides. These reports come from healthcare professionals, consumers, and manufacturers through the FDA Adverse Event Reporting System (FAERS). Note that the number of reports does not directly indicate the frequency of side effects, as adverse events are voluntarily reported and may be underrepresented.
The most frequently reported adverse events for Docusate Sodium And Sennosides include Fatigue, Nausea, Constipation, Diarrhoea, Dyspnoea. By volume, the top reported reactions are: Fatigue (501 reports), Nausea (494 reports), Constipation (405 reports). These figures reflect FDA adverse event reports and may not represent the true incidence rate of these side effects in all patients taking Docusate Sodium And Sennosides.
Out of 5,490 classified reports, 3,260 (59.4%) were classified as serious and 2,230 as non-serious. The FDA classifies an event as "serious" if it results in death, hospitalization, disability, or other medically significant outcomes. A higher serious-event ratio warrants closer attention but does not necessarily mean the drug is unsafe.
Adverse event reports for Docusate Sodium And Sennosides break down by patient sex as follows: Female: 3,326, Male: 2,024, Unknown: 6. This distribution reflects reporting patterns rather than actual risk differences between groups. Reporting rates can be influenced by prescribing patterns, disease demographics, and reporting behavior.
The most frequently reported age groups for Docusate Sodium And Sennosides adverse events are: age 68: 115 reports, age 69: 105 reports, age 72: 102 reports, age 71: 94 reports, age 66: 92 reports. Age-related reporting patterns can reflect both the demographics of the patient population and potential age-related susceptibility to certain side effects.
The primary manufacturer associated with Docusate Sodium And Sennosides adverse event reports is Walgreens. Multiple manufacturers may produce generic versions of this drug. The manufacturer listed reflects the most frequently reported brand in FDA adverse event data.
Beyond the most common reactions, other reported adverse events for Docusate Sodium And Sennosides include: Pain, Fall, Asthenia, Headache, Drug Ineffective. Less common side effects can still be clinically significant. Patients should report any unusual symptoms to their healthcare provider.
You can report adverse events from Docusate Sodium And Sennosides to the FDA through their MedWatch program at www.fda.gov/medwatch, by calling 1-800-FDA-1088, or by completing Form FDA 3500. Healthcare professionals, consumers, and manufacturers can all submit reports. Reporting helps the FDA monitor drug safety after approval.
Docusate Sodium And Sennosides has a safety concern score of 65 out of 100 (elevated concern). This score is calculated from the ratio of serious to non-serious adverse events, the diversity of reported reactions, and the overall volume of reports relative to usage. Fatigue and nausea are the most common side effects, with a significant number of reports involving serious adverse events like pneumonia and death.
Key safety signals identified in Docusate Sodium And Sennosides's adverse event data include: Serious adverse events like pneumonia and death are reported, indicating potential risks.. A wide range of reactions, including neurological and respiratory issues, suggest diverse safety concerns.. Reports of cardiovascular issues, though less frequent, are notable.. These signals are derived from patterns in FDA reports and should be discussed with a healthcare provider for personalized assessment.
DocuSate Sodium and Sennosides may interact with other medications, particularly those affecting the cardiovascular system, and should be used with caution. Always inform your healthcare provider about all medications, supplements, and over-the-counter drugs you are taking before starting Docusate Sodium And Sennosides.
Monitor for signs of serious adverse events such as pneumonia, heart issues, and gastrointestinal problems. Follow prescribed dosages and use as directed to minimize the risk of side effects.
Docusate Sodium And Sennosides has 13,062 adverse event reports on file with the FDA. The drug is associated with a range of gastrointestinal issues, including constipation, diarrhea, and abdominal pain. The volume of reports for Docusate Sodium And Sennosides reflects both the drug's usage level and the vigilance of the reporting community.
The FDA has received a significant number of adverse event reports, suggesting a need for ongoing monitoring and potential regulatory action. For the most current regulatory information, check the FDA's drug labeling database or consult your pharmacist.
Explore other medications manufactured by Walgreens and compare their safety profiles:
The following drugs share commonly reported adverse reactions with DOCUSATE SODIUM AND SENNOSIDES:
Drugs related to DOCUSATE SODIUM AND SENNOSIDES based on therapeutic use, drug class, or shared indications: